Literature DB >> 28863076

Histologic Correlates of Clinical and Endoscopic Severity in Children Newly Diagnosed With Ulcerative Colitis.

Brendan Boyle1, Margaret H Collins, Zhu Wang, David Mack, Anne Griffiths, Cary Sauer, James Markowitz, Neal LeLeiko, David Keljo, Joel Rosh, Susan S Baker, Marian Pfefferkorn, Melvin Heyman, Ashish Patel, Robert Baldassano, Joshua Noe, Paul Rufo, Subra Kugathasan, Thomas Walters, Lee Denson, Jeffrey Hyams.   

Abstract

To characterize rectal histology in an inception cohort of children newly diagnosed with ulcerative colitis (UC) and to explore its relationship with clinical indices of disease severity. The PROTECT (Predicting Response to Standardized Pediatric Colitis Therapy) Study enrolled children 17 years of age and younger newly diagnosed with UC. Baseline rectal biopsies were evaluated for acute and chronic inflammation, eosinophilic inflammation (peak eosinophil count > 32 eosinophils/high powered field, eosinophilic cryptitis or abscesses), and architectural/nonarchitectural chronic changes. Correlation with clinical indices including Mayo endoscopy subscore and Pediatric Ulcerative Colitis Activity Index was performed. Rectal biopsies from 369 patients (mean age, 12.9±3.1 y, 50% female) were reviewed. Cryptitis was found in 89%, crypt abscesses in 25%, and eosinophilic inflammation in 58%. Crypt distortion/atrophy was present in 98% of specimens. Higher grades of acute and chronic inflammation were associated with the presence of basal plasmacytosis (P<0.0001), basal lymphoid aggregates (P<0.0001), and surface villiform changes (P<0.0001). A severe Mayo endoscopy subscore was most common among those with severe acute and chronic inflammation, although this relationship was not linear. Severe Pediatric Ulcerative Colitis Activity Index scores were associated with the absence of or only mild eosinophilic inflammation (<32 eosinophils/high powered field) (P<0.03) and the presence of surface villiform changes (P<0.005). Acute and chronic inflammation, eosinophilic inflammation and chronic changes are common in children newly diagnosed with UC. The clinical and biological implication of low to absent eosinophilic inflammation and the presence of surface villiform changes requires further study.

Entities:  

Mesh:

Year:  2017        PMID: 28863076      PMCID: PMC5636675          DOI: 10.1097/PAS.0000000000000939

Source DB:  PubMed          Journal:  Am J Surg Pathol        ISSN: 0147-5185            Impact factor:   6.394


  18 in total

1.  A quantitative evaluation of mucosal eosinophils in the pediatric gastrointestinal tract.

Authors:  A Lowichik; A G Weinberg
Journal:  Mod Pathol       Date:  1996-02       Impact factor: 7.842

2.  Prognostic value of serologic and histologic markers on clinical relapse in ulcerative colitis patients with mucosal healing.

Authors:  Talat Bessissow; Bart Lemmens; Marc Ferrante; Raf Bisschops; Kristel Van Steen; Karel Geboes; Gert Van Assche; Séverine Vermeire; Paul Rutgeerts; Gert De Hertogh
Journal:  Am J Gastroenterol       Date:  2012-11-13       Impact factor: 10.864

3.  Coated oral 5-aminosalicylic acid therapy for mildly to moderately active ulcerative colitis. A randomized study.

Authors:  K W Schroeder; W J Tremaine; D M Ilstrup
Journal:  N Engl J Med       Date:  1987-12-24       Impact factor: 91.245

4.  Intestinal macrophage/epithelial cell-derived CCL11/eotaxin-1 mediates eosinophil recruitment and function in pediatric ulcerative colitis.

Authors:  Richard Ahrens; Amanda Waddell; Luqman Seidu; Carine Blanchard; Rebecca Carey; Elizabeth Forbes; Maria Lampinen; Tara Wilson; Elizabeth Cohen; Keith Stringer; Edgar Ballard; Ariel Munitz; Huan Xu; Nancy Lee; James J Lee; Marc E Rothenberg; Lee Denson; Simon P Hogan
Journal:  J Immunol       Date:  2008-11-15       Impact factor: 5.422

5.  Differentiating ulcerative colitis from Crohn disease in children and young adults: report of a working group of the North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition and the Crohn's and Colitis Foundation of America.

Authors:  Athos Bousvaros; Donald A Antonioli; Richard B Colletti; Marla C Dubinsky; Jonathan N Glickman; Benjamin D Gold; Anne M Griffiths; Gareth P Jevon; Leslie M Higuchi; Jeffrey S Hyams; Barbara S Kirschner; Subra Kugathasan; Robert N Baldassano; Pierre A Russo
Journal:  J Pediatr Gastroenterol Nutr       Date:  2007-05       Impact factor: 2.839

6.  Histologic analysis of eosinophils and mast cells of the gastrointestinal tract in healthy Canadian children.

Authors:  Elizaveta Chernetsova; Katrina Sullivan; Joseph de Nanassy; Janice Barkey; David Mack; Ahmed Nasr; Dina El Demellawy
Journal:  Hum Pathol       Date:  2016-04-01       Impact factor: 3.466

7.  Pediatric patients with untreated ulcerative colitis may present initially with unusual morphologic findings.

Authors:  Jonathan N Glickman; Athos Bousvaros; Francis A Farraye; Anna Zholudev; Sonia Friedman; Helen H Wang; Alan M Leichtner; Robert D Odze
Journal:  Am J Surg Pathol       Date:  2004-02       Impact factor: 6.394

8.  Patterns of inflammation in mucosal biopsies of ulcerative colitis: perceived differences in pediatric populations are limited to children younger than 10 years.

Authors:  M E Robert; L Tang; L M Hao; M Reyes-Mugica
Journal:  Am J Surg Pathol       Date:  2004-02       Impact factor: 6.394

Review 9.  Diagnosing eosinophilic colitis: histopathological pattern or nosological entity?

Authors:  Alan W H Bates
Journal:  Scientifica (Cairo)       Date:  2013-05-09

10.  Paneth cell metaplasia in newly diagnosed inflammatory bowel disease in children.

Authors:  Naomi Simmonds; Mark Furman; Evi Karanika; Alan Phillips; Alan W H Bates
Journal:  BMC Gastroenterol       Date:  2014-05-15       Impact factor: 3.067

View more
  9 in total

1.  Clinical and biological predictors of response to standardised paediatric colitis therapy (PROTECT): a multicentre inception cohort study.

Authors:  Jeffrey S Hyams; Sonia Davis Thomas; Nathan Gotman; Yael Haberman; Rebekah Karns; Melanie Schirmer; Angela Mo; David R Mack; Brendan Boyle; Anne M Griffiths; Neal S LeLeiko; Cary G Sauer; David J Keljo; James Markowitz; Susan S Baker; Joel Rosh; Robert N Baldassano; Ashish Patel; Marian Pfefferkorn; Anthony Otley; Melvin Heyman; Joshua Noe; Maria Oliva-Hemker; Paul A Rufo; Jennifer Strople; David Ziring; Stephen L Guthery; Boris Sudel; Keith Benkov; Prateek Wali; Dedrick Moulton; Jonathan Evans; Michael D Kappelman; M Alison Marquis; Francisco A Sylvester; Margaret H Collins; Suresh Venkateswaran; Marla Dubinsky; Vin Tangpricha; Krista L Spada; Bradley Saul; Jessie Wang; Jose Serrano; Kevin Hommel; Urko M Marigorta; Greg Gibson; Ramnik J Xavier; Subra Kugathasan; Thomas Walters; Lee A Denson
Journal:  Lancet       Date:  2019-03-29       Impact factor: 79.321

2.  Association Between Endoscopic and Histologic Findings in a Multicenter Retrospective Cohort of Patients with Non-esophageal Eosinophilic Gastrointestinal Disorders.

Authors:  Robert D Pesek; Craig C Reed; Margaret H Collins; Amanda B Muir; Patricia C Fulkerson; Calies Menard-Katcher; Gary W Falk; Jonathan Kuhl; Adam Z Magier; Faria N Ahmed; Maureen Demarshall; Ankur Gupta; Jonathan Gross; Tokunbo Ashorobi; Christina L Carpenter; Jeffrey P Krischer; Nirmala Gonsalves; Ikuo Hirano; Jonathan M Spergel; Sandeep K Gupta; Glenn T Furuta; Marc E Rothenberg; Evan S Dellon
Journal:  Dig Dis Sci       Date:  2019-11-26       Impact factor: 3.199

3.  Distinct Histopathological Features at Diagnosis of Very Early Onset Inflammatory Bowel Disease.

Authors:  Máire A Conrad; Chrystalle Katte Carreon; Noor Dawany; Pierre Russo; Judith R Kelsen
Journal:  J Crohns Colitis       Date:  2019-04-26       Impact factor: 9.071

4.  Tissue-based Gene Expression as Potential Biomarkers for IBD Course.

Authors:  Yael Haberman
Journal:  Inflamm Bowel Dis       Date:  2020-09-18       Impact factor: 5.325

5.  Serologic Reactivity Reflects Clinical Expression of Ulcerative Colitis in Children.

Authors:  Elizabeth A Spencer; Sonia M Davis; David R Mack; Brendan M Boyle; Anne M Griffiths; Neal S LeLeiko; Cary G Sauer; David J Keljo; James F Markowitz; Susan S Baker; Joel R Rosh; Robert N Baldassano; Maria Oliva-Hemker; Marian D Pfefferkorn; Anthony R Otley; Melvin B Heyman; Joshua D Noe; Ashish S Patel; Paul A Rufo; M Alison Marquis; Thomas D Walters; Margaret H Collins; Subra Kugathasan; Lee A Denson; Jeffrey S Hyams; Marla C Dubinsky
Journal:  Inflamm Bowel Dis       Date:  2018-05-18       Impact factor: 5.325

6.  Clinical and Host Biological Factors Predict Colectomy Risk in Children Newly Diagnosed With Ulcerative Colitis.

Authors:  Jeffrey S Hyams; Michael Brimacombe; Yael Haberman; Thomas Walters; Greg Gibson; Angela Mo; David Mack; Anne Griffiths; Brendan Boyle; Neal LeLeiko; James Markowitz; Joel Rosh; Ashish Patel; Sapana Shah; Robert Baldassano; Marian Pfefferkorn; Cary Sauer; Joelynn Dailey; Suresh Venkateswaran; Subra Kugathasan; Lee A Denson
Journal:  Inflamm Bowel Dis       Date:  2022-02-01       Impact factor: 5.325

7.  Outcomes of inflammatory bowel disease in patients with eosinophil-predominant colonic inflammation.

Authors:  Tarik Alhmoud; Anas Gremida; Diego Colom Steele; Imaneh Fallahi; Wael Tuqan; Nina Nandy; Mahmoud Ismail; Barakat Aburajab Altamimi; Meng-Jun Xiong; Audra Kerwin; David Martin
Journal:  BMJ Open Gastroenterol       Date:  2020-02-16

Review 8.  Endoscopic and Histologic Predictors of Outcomes in Pediatric Ulcerative Colitis-Caveat Emptor.

Authors:  Lorraine Stallard; Séamus Hussey
Journal:  Front Pediatr       Date:  2021-06-23       Impact factor: 3.418

9.  Ulcerative colitis mucosal transcriptomes reveal mitochondriopathy and personalized mechanisms underlying disease severity and treatment response.

Authors:  Yael Haberman; Rebekah Karns; Phillip J Dexheimer; Melanie Schirmer; Judith Somekh; Ingrid Jurickova; Tzipi Braun; Elizabeth Novak; Laura Bauman; Margaret H Collins; Angela Mo; Michael J Rosen; Erin Bonkowski; Nathan Gotman; Alison Marquis; Mason Nistel; Paul A Rufo; Susan S Baker; Cary G Sauer; James Markowitz; Marian D Pfefferkorn; Joel R Rosh; Brendan M Boyle; David R Mack; Robert N Baldassano; Sapana Shah; Neal S Leleiko; Melvin B Heyman; Anne M Grifiths; Ashish S Patel; Joshua D Noe; Bruce J Aronow; Subra Kugathasan; Thomas D Walters; Greg Gibson; Sonia Davis Thomas; Kevin Mollen; Shai Shen-Orr; Curtis Huttenhower; Ramnik J Xavier; Jeffrey S Hyams; Lee A Denson
Journal:  Nat Commun       Date:  2019-01-03       Impact factor: 14.919

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.